Skip to main content
. 2021 Mar 10;413(11):2971–2984. doi: 10.1007/s00216-021-03231-9

Table 5.

Results of the stability assessments

Analyte Nominal concentration (pg/mL) Benchtop stability Freeze-thaw stability Long-term stability
1.5 h at 21 °C
RE (%)
3 h at 21 °C
RE (%)
1 cycle RE (%) 2 cycles RE (%) 4 cycles RE (%) 4 weeks
RE (%)
Kallidin QC high 750.0 −3.3 −9.6 1.1 −7.2 −10.3 −6.7
QC mid 125.0 −1.7 −10.8 −9.5 −2.1 −2.7 8.6
QC low 31.1 −4.4 −0.7* −4.4 1.4 −5.3 6.6
QC low 7.8 0.0 −0.8 12.4 −14.9 −6.5 14.9
Bradykinin QC high 750.0 −1.4 −7.4 0.4 −7.8 −8.3 −3.0
QC mid 125.0 −1.2 1.2 −3.2 −6.2 −10.8 5.9
QC low 31.1 1.4 8.4* −1.5 −6.2 −9.8 10.0
QC low 7.8 4.9 138.0 −1.5 1.6 −7.3 4.5
Des-Arg(10)-kallidin QC high 750.0 −0.9 −11.2 6.1 −8.4 −7.9 −2.1
QC mid 125.0 6.9 −2.4 −0.8 −7.7 −7.7 0.9
QC low 31.1 13.1 −7.9* −1.2 0.4 −8.6 13.8
QC low 7.8 9.7 9.4 −11.8 0.8 3.5 10.6
Des-Arg(9)-bradykinin QC high 750.0 −4.6 −21.8 −0.3 −8.4 −7.9 0.5
QC mid 125.0 1.1 −16.1 2.1 −7.7 −7.7 3.3
QC low 31.1 3.4 −5.2* 5.4 0.4 −8.6 12.3
QC low 7.8 −10.2 11.8 −11.7 0.8 3.5 8.2
Bradykinin 2-9 QC high 750.0 −3.3 −9.1 −1.1 −7.2 −10.6 −0.6
QC mid 125.0 −2.4 −8.0 −0.5 −12.2 −11.7 1.7
QC low 31.1 4.7 3.8* 11.8 −4.7 −0.5 9.0
Bradykinin 1-7 QC high 750.0 1.7 2.1 2.0 −6.6 −7.0 −2.6
QC mid 125.0 9.0 3.6 −1.3 −2.6 −6.1 6.0
QC low 31.1 3.1 10.7* 4.0 −6.3 −15.3 7.5
QC low 7.8 11.8 16.0 −7.3 0.3 −12.3 13.6
Bradykinin 1-5 QC high 750.0 −0.6 −7.6 4.0 −8.0 −20.3 −11.0
QC mid 125.0 −1.1 −2.6 −8.3 −5.8 −14.1 11.3
QC low 31.1 −8.7 −5.3* −5.4 −2.8 −30.6 13.9

*n = 1; QC quality control, RE relative error